Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2019-11-21 Regulatory Filings
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Medistims nyeste generasjon MiraQ™ er klarert for salg i Canada
Regulatory Filings Classification · 100% confidence The document is a short announcement dated November 21, 2019, from Medistim ASA, written in Norwegian. It states that their new product, MiraQ, has received clearance from Health Canada for sale in the Canadian market. The text explicitly mentions that this information is subject to disclosure requirements under Norwegian law ('Denne opplysningen er informasjonspliktig etter norsk lov'). This type of material, which announces a significant business event or regulatory clearance without being a full financial report (like 10-K or IR) or a transcript, typically falls under general regulatory announcements. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a mandatory, non-standardized regulatory disclosure that isn't a specific financial report or management change. It is not an Earnings Release (ER), Management Discussion (MDA), or a specific capital/share action (CAP/SHA/POS). Since it's a short, mandatory disclosure, RNS is the best fit.
2019-11-21 Norwegian
Resultater for Medistim ASA per 3 kvartal 2019
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the third quarter of 2019 (3. kvartal 2019) for Medistim. It contains detailed financial statements, including revenue, EBIT, balance sheet data, operational status by region, and management commentary on financial performance. It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q3 2019
2019-10-24 Norwegian
Results for Medistim ASA as of the 3rd quarter 2019
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly financial report for Medistim for the 3rd quarter of 2019. It contains detailed financial statements, including sales data, operating profit (EBIT), balance sheet information, and management commentary on operational status and market trends. It is not an announcement of a report (RPA) or a simple earnings release (ER), as it provides substantive financial analysis and data tables. Therefore, it is classified as an Interim/Quarterly Report. Q3 2019
2019-10-24 English
Resultater for Medistim ASA per 3 kvartal 2019
Investor Presentation Classification · 99% confidence The document is titled "Medistim ASA Third quarter 2019" and contains detailed financial statements for Q3 2019 and YTD September 2019, including Profit and Loss statements, Balance Sheets, and segment revenue breakdowns. The content is comprehensive, covering financial performance, business updates, and strategy implementation, which is characteristic of a formal periodic financial report. Since it covers a period shorter than a full year (Q3), it fits the definition of an Interim/Quarterly Report (IR). It is not merely an announcement of a report (RPA) as it contains the full data, nor is it the Annual Report (10-K).
2019-10-24 English
Results for Medistim ASA as of the 3rd quarter 2019
Investor Presentation Classification · 99% confidence The document is titled "Medistim ASA Third quarter 2019" and contains detailed financial statements for Q3 2019 and YTD September 2019, including Profit and Loss statements, Balance Sheets, and segment revenue breakdowns. The content is comprehensive, covering financial performance, business updates, and strategy implementation, which is characteristic of a formal periodic financial report. Since it covers a period shorter than a full year (Q3), it fits the definition of an Interim/Quarterly Report (IR). It is not merely an announcement of a report (RPA) as it contains the full data, nor is it the Annual Report (10-K).
2019-10-24 English
Resultater for Medistim ASA per 3 kvartal 2019
Earnings Release Classification · 100% confidence The document text provides key financial highlights for Medistim ASA for the 3rd quarter of 2019 (3 kvartal 2019). It details revenue (Omsetningen), operating result (Driftsresultatet/EBIT), and unit sales growth for the quarter and year-to-date. This structure—presenting key performance indicators immediately following the period end—is characteristic of an Earnings Release (ER), which is the initial announcement of periodical financial results, typically shorter than a full Interim Report (IR). Given the brevity and focus on headline figures, ER is the most appropriate classification. 9M 2019
2019-10-24 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.